(A) 1-year follow-up period | (B) Follow-up between months 1–12 | |
---|---|---|
CP score | ||
AUC ± SD | 0.865 ± 0.040 | 0.855 ± 0.050 |
p | < 0.001 | < 0.001 |
95% C.I. | 0.787 – 0.943 | 0.757 – 0.953 |
MELD score | ||
AUC ± SD | 0.739 ± 0.052 | 0.740 ± 0.058 |
p | < 0.001 | 0.001 |
95% C.I. | 0.637 – 0.871 | 0.626 – 0.854 |
Serum AHSG | ||
AUC ± SD | 0.937 ± 0.025 | 0.908 ± 0.035 |
p | < 0.001 | 0.001 |
95% C.I. | 0.889 – 0.986 | 0.839 – 0.978 |
CP score < 10, ≥ 10 | ||
Relative Risk | 3.878 | 4.838 |
p | < 0.001 | < 0.001 |
95% C.I. | 1.998 – 7.527 | 2.009 – 11.649 |
Sensitivity at this cutoff value | 0.753 | 0.675 |
Specificity at this cutoff value | 0.827 | 0.755 |
MELD score < 20, ≥ 20 | ||
Relative Risk | 2.205 | 2.4167 |
p | 0.002 | 0.011 |
95% C.I. | 1.318 – 3.689 | 1.229 – 4.952 |
Sensitivity at this cutoff value | 0.595 | 0.587 |
Specificity at this cutoff value | 0.729 | 0.720 |
AHSG < 365 μg/ml, ≥ 365 μg/ml | ||
Relative Risk | 9.874 | 9.257 |
p | < 0.001 | < 0.001 |
95% C.I. | 4.258 – 22.898 | 3.945 – 21.724 |
Sensitivity at this cutoff value | 0.865 | 0.783 |
Specificity at this cutoff value | 0.942 | 0.936 |
AHSG < 300 μg/ml, ≥ 300 μg/ml | ||
Relative Risk | 4.209 | 4.813 |
p | < 0.001 | < 0.001 |
95% C.I. | 2.675 – 6.622 | 2.813 – 8.233 |
Sensitivity at this cutoff value | 0.594 | 0.478 |
Specificity at this cutoff value | 0.981 | 0.972 |